Selected article for: "asymptomatic individual and cc ND international license"
Author: Quan-xin Long; Hai-jun Deng; Juan Chen; Jieli Hu; Bei-zhong Liu; Pu Liao; Yong Lin; Li-hua Yu; Zhan Mo; Yin-yin Xu; Fang Gong; Gui-cheng Wu; Xian-xiang Zhang; Yao-kai Chen; Zhi-jie Li; Kun Wang; Xiao-li Zhang; Wen-guang Tian; Chang-chun Niu; Qing-jun Yang; Jiang-lin Xiang; Hong-xin Du; Hua-wen Liu; Chunhui Lang; Xiao-he Luo; Shao-bo Wu; Xiao-ping Cui; Zheng Zhou; Jing Wang; Cheng-jun Xue; Xiao-feng Li; Li Wang; Xiao-jun Tang; Yong Zhang; Jing-fu Qiu; Xia-mao Liu; Jin-jing Li; De-chun Zhang; Fan Zhang; Xue-fei Cai; Deqiang Wang; Yuan Hu; Ji-hua Ren; Ni Tang; Ping Liu; Qin Li; Ai-long Huang
Title: Antibody responses to SARS-CoV-2 in COVID-19 patients: the perspective application of serological tests in clinical practice
  • Document date: 2020_3_20
    • ID: dm8yl4xu_41
    Snippet: Asymptomatic individual with infection will become a transmission source if not be contained and quarantined. We surveyed a cohort of 164 close contacts and identified 4.3% (7/164) patients with occult infection which were missed by symptoms screening and nucleic acid test. Adding those identified by RT-PCR, the percentage of asymptomatic infection was as high as 6.1% in this cohort. Thus, it is necessary to . CC-BY-NC-ND 4.0 International licens.....
    Document: Asymptomatic individual with infection will become a transmission source if not be contained and quarantined. We surveyed a cohort of 164 close contacts and identified 4.3% (7/164) patients with occult infection which were missed by symptoms screening and nucleic acid test. Adding those identified by RT-PCR, the percentage of asymptomatic infection was as high as 6.1% in this cohort. Thus, it is necessary to . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • asymptomatic individual and infection asymptomatic individual: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • asymptomatic individual and infection asymptomatic individual transmission source: 1
    • asymptomatic individual and International license: 1
    • asymptomatic individual and transmission source: 1
    • asymptomatic infection and cc NC ND International license: 1, 2, 3, 4, 5, 6, 7, 8
    • asymptomatic infection and close contact: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • asymptomatic infection and infection asymptomatic individual: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • asymptomatic infection and infection asymptomatic individual transmission source: 1
    • asymptomatic infection and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • asymptomatic infection and nucleic acid test: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • asymptomatic infection and RT PCR identify: 1, 2
    • asymptomatic infection and transmission source: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • cc NC ND International license and close contact: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • cc NC ND International license and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cc NC ND International license and nucleic acid test: 1, 2, 3
    • cc NC ND International license and transmission source: 1, 2, 3
    • close contact and infection asymptomatic individual: 1, 2
    • close contact and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • close contact and nucleic acid test: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23